Kaifeng Mingren Pharmaceutical Co.,LTD.

Kaifeng Mingren Pharmaceutical Co.,Ltd. was Established in 2002 with Registered capital 50 million RMB. It is committed to research & development, production and sales. Main business including: APIs, intermediates, CDMO, formulation. Manufacture site located in Kaifeng, Henan province with the area of 350 thousand square meter and building area 14 thousand square meter, clean area 6 thousand square meter. Currently own Lyophilized powder for injection, Tablet, powder injection, tablet, granular, API and intermediate manufacturing plants. The company has the annual production capacity of 20 million bottles of powder injection, 300 tons of chemical raw materials, 360 tons of cephalosporin intermediates and 10 tons of sterile active pharmaceutical ingredients. In order to expend the business, a research and development center in Shanghai has been built and put into use. Lanzhou factory in Gansu Province is mainly responsible for the production of API, while Yancheng factory in Jiangsu Province is mainly responsible for the production of preparations. The company has a comprehensive and perfect GMP quality management system and EHS management system. The company shoulders the mission of "committed to quality service, enabling healthy life", providing customers with high standards of quality service, and has passed the Chinese GMP and EU CEP certification; After years of technology accumulation and industry precipitation, it has formed a number of core technology platforms, including small molecule API and intermediates development platform, peptide drug research technology platform, drug lyophilization preparation technology research platform, and the service scope covers anti-tumor, anti-virus, cardiovascular and cerebrovascular, digestive system, pain treatment and other fields. In order to improve research and development efficiency, the company continues to increase investment in hardware equipment, equipped with advanced scientific research facilities and production facilities, and established a multi-functional research and development laboratory and pharmaceutical research and development center. With a responsible attitude towards customers, society and employees, we have pushed forward the construction of four major systems: quality management system, EHS management system, protection system for IP, and legal system of medicines, for the purpose of ensuring the sustain development of the company. Over the course of development, we have been sticking to the business principles of people-oriented, scientific and technological innovation, serving the customers, benefiting mankind, and contributing to the cause of health of the worldwide.